One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
Sangamo Therapeutics ( NASDAQ:SGMO ) Full Year 2023 Results Key Financial Results Revenue: US$176.2m (up 58% from FY...